Alderman C P
Department of Pharmacy, Repatriation General Hospital, Daw Park, Adelaide, South Australia, Australia.
Drug Saf. 2000 Feb;22(2):103-9. doi: 10.2165/00002018-200022020-00003.
Drug interactions are a common and serious problem arising from polypharmacy. Strategies to reduce the likelihood of the co-prescription of hazardous drug combinations are likely to enhance the quality of care provided for patients requiring polypharmacotherapy. Drugs for which patient-oriented information strategies may decrease the likelihood of drug interactions tend to be those of low therapeutic index. and have interaction potential with other drugs commonly prescribed or available without prescription.
药物相互作用是联合用药时常见且严重的问题。降低有害药物组合联合处方可能性的策略,可能会提高需要接受联合药物治疗的患者的护理质量。以患者为导向的信息策略可能会降低药物相互作用可能性的药物,往往是治疗指数较低且与其他常用处方药或非处方药有相互作用潜力的药物。